Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Astex Pharmaceuticals Inc.
Headquarters: Dublin, CA, United States of America
Website: N/A
Year Founded: 1991
Status: Acquired
BioCentury | Feb 16, 2024
Management Tracks
CEO Hanson leaving enGene
Plus: Compugen names Mahler CMO and updates from Merck, Navega, RAPT and Ocuphire
BioCentury | Aug 10, 2023
Finance
Aug. 9 Quick Takes: Alltrna raises $109M for unified approach to stop codon diseases
Plus: Venture cash for ADARx, Georgiamune, Neurophth and updates from Regeneron-Decibel, Novartis, Sunbird-Glympse, Denali-Takeda and more
BioCentury | Jan 7, 2020
Company News
In deal with Taiho and Astex, Merck gains another K-Ras program
Merck gains another avenue to a target of growing importance via a deal with two Otsuka subsidiaries
BioCentury | Jun 7, 2019
Clinical News
June 7 Clinical Quick Takes: Takeda discontinues Ninlaro for amyloidosis; plus La Jolla, Innovent and Atara
BioCentury | Apr 19, 2019
Product Development
Companies poised to take Chinese checkpoints global
Three companies poised to answer Pazdur’s call for Chinese PD-1 inhibitors
Items per page:
1 - 10 of 120